Resveratrol Stabilizes Aortic Growth in Marfan?

I have recently been diagnosed with Marfan Syndrome. I am also a cancer survivor whose conventional therapies left me with a host of long-term and late stage side effects. As a result, I would prefer not to undergo any conventional treatments for my heart. According to the research below, resveratrol stabilizes aortic growth in Marfan patients.

My aortic root and my descending aorta both are slightly larger than “normal.” I am relying on many of the non-conventional therapies listed below to also slow any growth.

Which non-conventional therapies can stabilize aortic growth?

1. Nutritional Approaches

Omega-3 Fatty Acids: Found in fish oil, omega-3s have anti-inflammatory properties that may reduce vascular inflammation and slow aneurysm growth.
Antioxidant-Rich Diet: Diets high in fruits, vegetables, and foods rich in antioxidants (like vitamins C and E) may help protect against oxidative stress, a contributing factor to aneurysm progression.
Magnesium: Some studies suggest that magnesium might help support vascular health, but its effect on aortic aneurysms is still being explored.

2. Herbal Supplements

Curcumin (Turmeric): Known for its anti-inflammatory and antioxidant properties, curcumin may have a protective effect on the cardiovascular system. While not directly proven to stabilize aortic growth, it can reduce overall inflammation, which could indirectly benefit vascular health.
Hawthorn: Traditionally used to support cardiovascular health, hawthorn may improve blood flow and reduce blood pressure, which can help slow aortic dilation.

3. Exercise and Yoga

Moderate Aerobic Exercise: While strenuous exercise is not recommended for individuals with aortic aneurysms, moderate aerobic exercise like walking or cycling can improve cardiovascular health and blood pressure control, potentially reducing the risk of aneurysm growth.
Yoga and Meditation: Practices that reduce stress can lower blood pressure and heart rate, minimizing strain on the aorta. Gentle yoga, breathing exercises, and meditation may support overall cardiovascular health.

4. Acupuncture

Some studies suggest that acupuncture might help in reducing stress, improving blood flow, and regulating blood pressure. Though not directly linked to aneurysm stabilization, acupuncture could be a beneficial adjunct to reduce risk factors.

5. Mind-Body Therapies

Mindfulness-Based Stress Reduction (MBSR): This technique has shown benefits in reducing blood pressure and managing stress, which can indirectly support the stability of aortic growth.
Biofeedback: Learning to control physiological functions such as blood pressure and heart rate through biofeedback may reduce strain on the cardiovascular system.

6. Probiotics

Emerging research suggests a potential link between gut health and vascular health. Certain probiotics might play a role in reducing systemic inflammation, which could theoretically influence aortic stability.

7. Lifestyle Modifications

Smoking Cessation: Quitting smoking is critical for vascular health, as smoking significantly increases the risk of aneurysm growth and rupture.
Alcohol Moderation: Limiting alcohol consumption is important because excessive alcohol can raise blood pressure and increase vascular stress.

8. Traditional Chinese Medicine (TCM)

TCM approaches, including herbal formulas and acupuncture, often focus on improving circulation and reducing inflammation. Some TCM herbs may have vasoprotective properties, though more clinical evidence is needed to support their use in aortic aneurysm management.

Important Considerations

Always consult a healthcare professional before beginning any non-conventional therapy, especially if you have an aortic aneurysm or are at risk for aortic dilation. Alternative treatments should complement, not replace, conventional medical care.

In the above video Dr. Castro mentions a range of 5.0 – 5.5 centimeters as the size of aortic root dilation for a person to consider surgery. My aortic root, as of my most recent echocardiogram, was 5.1 centimeters.

Further, Dr. Castro confirms that people that are greater than average height can have aortic roots that are greater than average.

I am 6’6″ in height. I will continue to rely on evidence-based non-conventional therapies to manage my aortic root dilation and also get an echo annually to keep an eye on things.

Are you a Marfan Syndrome survivor? Do you have any heart issues? How do you manage your Marfans?

Post below or email me at David.PeopleBeatingCancer@gmail.com

Thank you,

David Emerson

Cancer Survivor
Cancer Coach
Director PeopleBeatingCancer

Effects of resveratrol on aortic growth in patients with Marfan syndrome: a single-arm open-label multicentre trial

“Background Resveratrol, a dietary supplement that intervenes in cellular metabolism, has been shown to reduce aortic growth rate in a mouse model of Marfan syndrome (MFS), a condition associated in humans with life-threatening aortic complications, often preceded by aortic dilatation. The primary objective of this study was to investigate the effects of resveratrol on aortic growth rate in patients with MFS .

Methods In this investigator-initiated, single-arm open-label multicentre trial, we analysed resveratrol treatment in adults aged 18–50 years with MFS. The primary endpoint was the change in estimated annual aortic growth at five predefined levels in the thoracic aorta after 1 year of resveratrol treatment, evaluated using a linear mixed model. Aortic diameters were measured by cardiac MRI at three time points to analyse the annual aortic expansion rate before and after initiation of treatment. Additionally, annual aortic growth was compared with growth in a previously conducted losartan randomised clinical trial.

Results 898 patients were screened of which 19% (168/898) patients met the inclusion criteria.

36% (61/168) patients signed informed consent and 93% (57/61) aged 37±9 years, of which 28 males (49%) were included in the final analysis of the study. 46% (26/57) had undergone aortic root replacement prior to the study. Aortic root diameters remained stable after 1.2±0.3 years of resveratrol administration. A trend towards a decrease in estimated growth rate (mm/year) was observed in the aortic root (from 0.39±0.06 to −0.13±0.23, p=0.072), ascending aorta (from 0.40±0.05 to −0.01±0.18, p=0.072) and distal descending aorta (from 0.32±0.04 to 0.01±0.14, p=0.072).

Conclusion Resveratrol treatment for 1 year may stabilise the aortic growth rate in adult patients with MFS (resveratrol stabilizes aortic growth in Marfan patients). However, a subsequent randomised clinical trial with a longer follow-up duration and a larger study cohort is needed to establish an actual long-term beneficial effect of this dietary supplement in patients with MFS.